美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=REYATAZ"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
REYATAZ 021567 001 NDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No 2003/06/20 2003/06/20 BRISTOL MYERS SQUIBB Discontinued
REYATAZ 021567 002 NDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 150MG BASE Yes No 2003/06/20 2003/06/20 BRISTOL MYERS SQUIBB Prescription
REYATAZ 021567 003 NDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 200MG BASE Yes No 2003/06/20 2003/06/20 BRISTOL MYERS SQUIBB Prescription
REYATAZ 021567 004 NDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 300MG BASE Yes Yes 2003/06/20 2006/10/16 BRISTOL MYERS SQUIBB Prescription
REYATAZ 206352 001 NDA ATAZANAVIR SULFATE POWDER;ORAL EQ 50MG BASE/PACKET Yes Yes 2014/06/02 2014/06/02 BRISTOL MYERS SQUIBB Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2020 DrugFuture->U.S. FDA Drugs Database